In the world economic growth, the Cancer Biomarker industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Cancer Biomarker market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Cancer Biomarker market size will be further expanded, we expect that by 2024, The market size of the Cancer Biomarker will reach XXX million $.
Cancer biomarkers have recently attracted attention due to the ability to track the disease process before it develops, and thus, have a better prognosis and treatment prospect. These tests use a combination of molecular markers such as antibodies, transcript factors, tumor antigens, and molecules to identify the presence of certain diseases. The usefulness of these tests for cancer research has gained enormous momentum due to their capability to rule out potentially life-threatening diseases early in their development. Cancer biomarker testing thus far has had great success in identifying the disease processes and individual genetic abnormalities that lead to the development of various forms of cancer.
Market Dynamics
R&D in cancer biomarker is expected to propel growth of the global cancer biomarker market over the forecast period. For instance, in August 2021, researchers from René Gauducheau Cancer Centre, France, reported discovery of a protein which may be able to predict the outcome of breast cancers which have spread to the lymph nodes.
Availability of favorable insurance for biomarker testing is also expected to aid in growth of the market. For instance, from August 2021, biomarker testing would be covered under Medicaid as well as state-regulated insurance plans.
Major players operating in the global cancer biomarker market are focused on R&D to expand their product portfolio. For instance, in September 2021, OneOncology, a platform for independent community oncology practices, and Genentech, a member of the Roche Group, presented data in two abstracts examining genomic profiling and biomarker testing patterns in community oncology centers, as part of their multi-year strategic research partnership, at the 2021 ASCO Quality Care Symposium.
Key Takeaways
- R&D in cancer biomarker is expected to propel growth of the global cancer biomarker market over the forecast period
- Major players operating in the global cancer biomarker market are focused on R&D to expand their product portfolio. For instance, in August 2021, INmune Bio, Inc. announced that the first patient who received INKmune as a potential treatment for high-risk myelodysplastic syndrome successfully shown the NK activation and functional differentiation predicted by previously published in vitro experiments.
- Major players operating in the global cancer biomarker market include, Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen N.V., Illumina, GE Healthcare, Agilent Technologies, Biomérieux SA, Merck & Co., Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Myriad Genetics, Sysmex Corporation, Hologic, and Quest Diagnostics
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen N.V.
Illumina
GE Healthcare
Agilent Technologies
Biomérieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7):
Product Type Segmentation
Protein Biomarker
Genetic Biomarker
Industry Segmentation
Diagnostics
Research
Prognostics
Risk Assessment
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Table of Contents
Section 1 Cancer Biomarker Product Definition
Section 2 Global Cancer Biomarker Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Cancer Biomarker Shipments
2.2 Global Manufacturer Cancer Biomarker Business Revenue
2.3 Global Cancer Biomarker Market Overview
Section 3 Manufacturer Cancer Biomarker Business Introduction
3.1 Thermo Fisher Scientific Cancer Biomarker Business Introduction
3.1.1 Thermo Fisher Scientific Cancer Biomarker Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 Thermo Fisher Scientific Cancer Biomarker Business Distribution by Region
3.1.3 Thermo Fisher Scientific Interview Record
3.1.4 Thermo Fisher Scientific Cancer Biomarker Business Profile
3.1.5 Thermo Fisher Scientific Cancer Biomarker Product Specification
3.2 Bio-Rad Laboratories Cancer Biomarker Business Introduction
3.2.1 Bio-Rad Laboratories Cancer Biomarker Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 Bio-Rad Laboratories Cancer Biomarker Business Distribution by Region
3.2.3 Interview Record
3.2.4 Bio-Rad Laboratories Cancer Biomarker Business Overview
3.2.5 Bio-Rad Laboratories Cancer Biomarker Product Specification
3.3 Roche Diagnostics Cancer Biomarker Business Introduction
3.3.1 Roche Diagnostics Cancer Biomarker Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 Roche Diagnostics Cancer Biomarker Business Distribution by Region
3.3.3 Interview Record
3.3.4 Roche Diagnostics Cancer Biomarker Business Overview
3.3.5 Roche Diagnostics Cancer Biomarker Product Specification
3.4 Qiagen N.V. Cancer Biomarker Business Introduction
3.5 Illumina Cancer Biomarker Business Introduction
3.6 GE Healthcare Cancer Biomarker Business Introduction
…
Section 4 Global Cancer Biomarker Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Cancer Biomarker Market Size and Price Analysis 2014-2019
4.1.2 Canada Cancer Biomarker Market Size and Price Analysis 2014-2019
4.2 South America Country
4.2.1 South America Cancer Biomarker Market Size and Price Analysis 2014-2019
4.3 Asia Country
4.3.1 China Cancer Biomarker Market Size and Price Analysis 2014-2019
4.3.2 Japan Cancer Biomarker Market Size and Price Analysis 2014-2019
4.3.3 India Cancer Biomarker Market Size and Price Analysis 2014-2019
4.3.4 Korea Cancer Biomarker Market Size and Price Analysis 2014-2019
4.4 Europe Country
4.4.1 Germany Cancer Biomarker Market Size and Price Analysis 2014-2019
4.4.2 UK Cancer Biomarker Market Size and Price Analysis 2014-2019
4.4.3 France Cancer Biomarker Market Size and Price Analysis 2014-2019
4.4.4 Italy Cancer Biomarker Market Size and Price Analysis 2014-2019
4.4.5 Europe Cancer Biomarker Market Size and Price Analysis 2014-2019
4.5 Other Country and Region
4.5.1 Middle East Cancer Biomarker Market Size and Price Analysis 2014-2019
4.5.2 Africa Cancer Biomarker Market Size and Price Analysis 2014-2019
4.5.3 GCC Cancer Biomarker Market Size and Price Analysis 2014-2019
4.6 Global Cancer Biomarker Market Segmentation (Region Level) Analysis 2014-2019
4.7 Global Cancer Biomarker Market Segmentation (Region Level) Analysis
Section 5 Global Cancer Biomarker Market Segmentation (Product Type Level)
5.1 Global Cancer Biomarker Market Segmentation (Product Type Level) Market Size 2014-2019
5.2 Different Cancer Biomarker Product Type Price 2014-2019
5.3 Global Cancer Biomarker Market Segmentation (Product Type Level) Analysis
Section 6 Global Cancer Biomarker Market Segmentation (Industry Level)
6.1 Global Cancer Biomarker Market Segmentation (Industry Level) Market Size 2014-2019
6.2 Different Industry Price 2014-2019
6.3 Global Cancer Biomarker Market Segmentation (Industry Level) Analysis
Section 7 Global Cancer Biomarker Market Segmentation (Channel Level)
7.1 Global Cancer Biomarker Market Segmentation (Channel Level) Sales Volume and Share 2014-2019
7.2 Global Cancer Biomarker Market Segmentation (Channel Level) Analysis
Section 8 Cancer Biomarker Market Forecast 2019-2024
8.1 Cancer Biomarker Segmentation Market Forecast (Region Level)
8.2 Cancer Biomarker Segmentation Market Forecast (Product Type Level)
8.3 Cancer Biomarker Segmentation Market Forecast (Industry Level)
8.4 Cancer Biomarker Segmentation Market Forecast (Channel Level)
Section 9 Cancer Biomarker Segmentation Product Type
9.1 Protein Biomarker Product Introduction
9.2 Genetic Biomarker Product Introduction
Section 10 Cancer Biomarker Segmentation Industry
10.1 Diagnostics Clients
10.2 Research Clients
10.3 Prognostics Clients
10.4 Risk Assessment Clients
Section 11 Cancer Biomarker Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Cancer Biomarker Product Picture from Thermo Fisher Scientific
Chart 2014-2019 Global Manufacturer Cancer Biomarker Shipments (Units)
Chart 2014-2019 Global Manufacturer Cancer Biomarker Shipments Share
Chart 2014-2019 Global Manufacturer Cancer Biomarker Business Revenue (Million USD)
Chart 2014-2019 Global Manufacturer Cancer Biomarker Business Revenue Share
Chart Thermo Fisher Scientific Cancer Biomarker Shipments, Price, Revenue and Gross profit 2014-2019
Chart Thermo Fisher Scientific Cancer Biomarker Business Distribution
Chart Thermo Fisher Scientific Interview Record (Partly)
Figure Thermo Fisher Scientific Cancer Biomarker Product Picture
Chart Thermo Fisher Scientific Cancer Biomarker Business Profile
Table Thermo Fisher Scientific Cancer Biomarker Product Specification
Chart Bio-Rad Laboratories Cancer Biomarker Shipments, Price, Revenue and Gross profit 2014-2019
Chart Bio-Rad Laboratories Cancer Biomarker Business Distribution
Chart Bio-Rad Laboratories Interview Record (Partly)
Figure Bio-Rad Laboratories Cancer Biomarker Product Picture
Chart Bio-Rad Laboratories Cancer Biomarker Business Overview
Table Bio-Rad Laboratories Cancer Biomarker Product Specification
Chart Roche Diagnostics Cancer Biomarker Shipments, Price, Revenue and Gross profit 2014-2019
Chart Roche Diagnostics Cancer Biomarker Business Distribution
Chart Roche Diagnostics Interview Record (Partly)
Figure Roche Diagnostics Cancer Biomarker Product Picture
Chart Roche Diagnostics Cancer Biomarker Business Overview
Table Roche Diagnostics Cancer Biomarker Product Specification
3.4 Qiagen N.V. Cancer Biomarker Business Introduction
…
Chart United States Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart United States Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart Canada Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Canada Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart South America Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart South America Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart China Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart China Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart Japan Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Japan Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart India Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart India Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart Korea Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Korea Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart Germany Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Germany Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart UK Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart UK Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart France Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart France Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart Italy Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Italy Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart Europe Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Europe Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart Middle East Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Middle East Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart Africa Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart Africa Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart GCC Cancer Biomarker Sales Volume (Units) and Market Size (Million $) 2014-2019
Chart GCC Cancer Biomarker Sales Price ($/Unit) 2014-2019
Chart Global Cancer Biomarker Market Segmentation (Region Level) Sales Volume 2014-2019
Chart Global Cancer Biomarker Market Segmentation (Region Level) Market size 2014-2019
Chart Cancer Biomarker Market Segmentation (Product Type Level) Volume (Units) 2014-2019
Chart Cancer Biomarker Market Segmentation (Product Type Level) Market Size (Million $) 2014-2019
Chart Different Cancer Biomarker Product Type Price ($/Unit) 2014-2019
Chart Cancer Biomarker Market Segmentation (Industry Level) Market Size (Volume) 2014-2019
Chart Cancer Biomarker Market Segmentation (Industry Level) Market Size (Share) 2014-2019
Chart Cancer Biomarker Market Segmentation (Industry Level) Market Size (Value) 2014-2019
Chart Global Cancer Biomarker Market Segmentation (Channel Level) Sales Volume (Units) 2014-2019
Chart Global Cancer Biomarker Market Segmentation (Channel Level) Share 2014-2019
Chart Cancer Biomarker Segmentation Market Forecast (Region Level) 2019-2024
Chart Cancer Biomarker Segmentation Market Forecast (Product Type Level) 2019-2024
Chart Cancer Biomarker Segmentation Market Forecast (Industry Level) 2019-2024
Chart Cancer Biomarker Segmentation Market Forecast (Channel Level) 2019-2024
Chart Protein Biomarker Product Figure
Chart Protein Biomarker Product Advantage and Disadvantage Comparison
Chart Genetic Biomarker Product Figure
Chart Genetic Biomarker Product Advantage and Disadvantage Comparison
Chart Diagnostics Clients
Chart Research Clients
Chart Prognostics Clients
Chart Risk Assessment Clients
Request Discount 
Inquire Before Buy
